JP2013544235A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544235A5 JP2013544235A5 JP2013533226A JP2013533226A JP2013544235A5 JP 2013544235 A5 JP2013544235 A5 JP 2013544235A5 JP 2013533226 A JP2013533226 A JP 2013533226A JP 2013533226 A JP2013533226 A JP 2013533226A JP 2013544235 A5 JP2013544235 A5 JP 2013544235A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- antibody
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39367710P | 2010-10-15 | 2010-10-15 | |
| US61/393,677 | 2010-10-15 | ||
| US201161508723P | 2011-07-18 | 2011-07-18 | |
| US61/508,723 | 2011-07-18 | ||
| PCT/EP2011/067947 WO2012049278A1 (en) | 2010-10-15 | 2011-10-14 | Therapies for improving pulmonary function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013544235A JP2013544235A (ja) | 2013-12-12 |
| JP2013544235A5 true JP2013544235A5 (https=) | 2014-11-20 |
Family
ID=44800047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013533226A Pending JP2013544235A (ja) | 2010-10-15 | 2011-10-14 | 肺機能を改善する治療法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20130281876A1 (https=) |
| EP (1) | EP2627673B1 (https=) |
| JP (1) | JP2013544235A (https=) |
| CN (1) | CN103328506A (https=) |
| AU (1) | AU2011315499A1 (https=) |
| BR (1) | BR112013009055A2 (https=) |
| CA (1) | CA2814431A1 (https=) |
| DK (1) | DK2627673T3 (https=) |
| ES (1) | ES2645368T3 (https=) |
| HU (1) | HUE034005T2 (https=) |
| MX (1) | MX2013004212A (https=) |
| NO (1) | NO2627673T3 (https=) |
| PL (1) | PL2627673T3 (https=) |
| RU (1) | RU2013122123A (https=) |
| WO (1) | WO2012049278A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9574004B2 (en) | 2012-08-21 | 2017-02-21 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an IL-4R antagonist |
| WO2015057668A1 (en) * | 2013-10-15 | 2015-04-23 | Medimmune, Llc | Methods for treating chronic obstructive pulmonary disease using benralizumab |
| CA2937387A1 (en) * | 2014-01-27 | 2015-07-30 | Medimmune, Llc | Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung |
| IL315136A (en) * | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| CA2943326A1 (en) | 2014-04-11 | 2015-10-15 | Novartis Ag | Methods of selectively treating asthma using il-13 antagonists |
| AU2016205188A1 (en) | 2015-01-09 | 2017-06-22 | Medimmune, Llc | Assay to detect human DPP-4 |
| CN104605857A (zh) * | 2015-02-12 | 2015-05-13 | 上海朔茂网络科技有限公司 | 一种肺功能测量方法 |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| BR112019018022A2 (pt) * | 2017-03-01 | 2020-06-02 | Medimmune Limited | Formulações de anticorpos monoclonais |
| US11053309B2 (en) | 2017-08-04 | 2021-07-06 | Regeneron Pharmaceuticals, Inc. | Methods for treating active eosinophilic esophagitis |
| MX2021010560A (es) | 2019-03-06 | 2021-11-12 | Regeneron Pharma | Inhibidores de la via il-4/il-13 para una eficacia aumentada en el tratamiento de cancer. |
| CA3132587A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| BR112022000740A2 (pt) | 2019-07-16 | 2022-07-05 | Sanofi Biotechnology | Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r |
| JP2023536159A (ja) * | 2020-07-31 | 2023-08-23 | ジェネンテック， インコーポレイテッド | 炎症性呼吸器疾患の増悪を治療するための方法 |
| CN112341543B (zh) * | 2021-01-11 | 2021-04-23 | 广东赛尔生物科技有限公司 | 包含间充质干细胞外泌体的药物组合物在治疗疾病中的应用 |
| US20230220089A1 (en) | 2021-12-30 | 2023-07-13 | Regeneron Pharmaceuticals, Inc. | Methods for attenuating atopic march by administering an il-4/il-13 antagonist |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2140660A1 (en) * | 1993-06-13 | 1994-12-22 | Uwe R. Juergens | Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| GB0004016D0 (en) | 2000-02-22 | 2000-04-12 | Royal Brompton Hospital | Biological material and uses thereof |
| GB0407315D0 (en) * | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| EP1824886B1 (en) * | 2004-11-17 | 2010-12-22 | Amgen Inc. | Fully human monoclonal antibodies to il-13 |
| GB0600488D0 (en) * | 2006-01-11 | 2006-02-22 | Glaxo Group Ltd | Immunoglobulins |
-
2011
- 2011-10-14 WO PCT/EP2011/067947 patent/WO2012049278A1/en not_active Ceased
- 2011-10-14 DK DK11769881.1T patent/DK2627673T3/da active
- 2011-10-14 CN CN2011800498365A patent/CN103328506A/zh active Pending
- 2011-10-14 EP EP11769881.1A patent/EP2627673B1/en not_active Not-in-force
- 2011-10-14 RU RU2013122123/10A patent/RU2013122123A/ru not_active Application Discontinuation
- 2011-10-14 JP JP2013533226A patent/JP2013544235A/ja active Pending
- 2011-10-14 NO NO11769881A patent/NO2627673T3/no unknown
- 2011-10-14 US US13/879,261 patent/US20130281876A1/en not_active Abandoned
- 2011-10-14 ES ES11769881.1T patent/ES2645368T3/es active Active
- 2011-10-14 CA CA2814431A patent/CA2814431A1/en not_active Abandoned
- 2011-10-14 AU AU2011315499A patent/AU2011315499A1/en not_active Abandoned
- 2011-10-14 HU HUE11769881A patent/HUE034005T2/en unknown
- 2011-10-14 MX MX2013004212A patent/MX2013004212A/es unknown
- 2011-10-14 PL PL11769881T patent/PL2627673T3/pl unknown
- 2011-10-14 BR BR112013009055A patent/BR112013009055A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544235A5 (https=) | ||
| EP2627673B1 (en) | Therapies for improving pulmonary function | |
| JP6637113B2 (ja) | Ｉｌ−４ｒアンタゴニストを投与することによるアトピー性皮膚炎を処置するための方法 | |
| AU2018253118B2 (en) | Treatment of asthma with anti-TSLP antibody | |
| RU2713406C2 (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| RS58091B1 (sr) | Metode za tretiranje ili prevenciju astme davanjem antagonista il-4r | |
| JP2022513717A (ja) | 好中球性病態の治療方法 | |
| KR20240052871A (ko) | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 | |
| JP2026068738A (ja) | Ｉｌ－３３アンタゴニストおよび／またはｉｌ－４ｒアンタゴニストを投与することによりアレルギー性喘息を治療するまたは予防するための方法 | |
| JP7495403B2 (ja) | 巨細胞性動脈炎の治療 | |
| KR20230054444A (ko) | 호흡기 질환 치료에 사용하기 위한 (1r,3s)-3-((5-시아노-4-페닐티아졸-2-일)카바모일)사이클로펜탄-1-카르복시산 및 이의 유도체 | |
| TW201842933A (zh) | 使用il-17拮抗劑選擇性治療氣喘的方法 | |
| US20250002598A1 (en) | Methods of Treating Asthma with Anti-LIGHT Antibodies | |
| HK40114122A (zh) | 用抗light抗体治疗哮喘的方法 | |
| CN118488968A (zh) | 用抗light抗体治疗哮喘的方法 | |
| TW202544036A (zh) | 用抗ｔｓｌｐ抗體治療慢性阻塞性肺病 | |
| WO2026041740A1 (en) | Treatment of high-risk asthma by blocking il-13 and tslp | |
| JP2025540348A (ja) | 筋炎の処置及び予防のための、抗ｉｌｔ７結合剤 | |
| HK1188603B (en) | Therapies for improving pulmonary function | |
| HK1188603A (en) | Therapies for improving pulmonary function | |
| WO2024146630A1 (zh) | 一种tslp抗体治疗哮喘的方法 | |
| KR20260013478A (ko) | 항-tslp 항체를 사용한 코르티코스테로이드 의존성 천식의 치료 | |
| KR20200069388A (ko) | Ｉｌ-4ｒ 길항제 투여로 아토피성 피부염을 치료하는 방법 |